Characterization of glucocorticoid receptor and hepatocyte nuclear factor 4α (HNF4α) binding to the hnf4α gene in the liver

Biochimie

Volumn 91, Issue 9, 2009, Pages 1095-1103

  Bailly, Alain ^a   Briançon, Nadège ^a   Weiss, Mary C ^a  

^a CNRS   (France)

Author keywords

Chromatin immunoprecipitation (ChIP); hnf4 Enhancers; hnf4 Promoters; HNF4 7; Liver development

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; TRANSCRIPTION FACTOR SP1;

ANIMAL TISSUE; ARTICLE; AUTOREGULATION; CELL DIFFERENTIATION; CELL ISOLATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EMBRYO DEVELOPMENT; ENHANCER REGION; GENE INDUCTION; GENE MAPPING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL; LIVER DEVELOPMENT; LIVER FUNCTION; LIVER PARENCHYMA; MALE; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; TRANSACTIVATION; TRANSCRIPTION INITIATION;

ANIMALS; BINDING SITES; CHROMATIN IMMUNOPRECIPITATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEPATOCYTE NUCLEAR FACTOR 4; LIVER; MALE; MICE; MICE, INBRED C57BL; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECEPTORS, GLUCOCORTICOID;

EID: 67651230378     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2009.06.009     Document Type: Article

References (54)

1. Cereghini S. Liver-enriched transcription factors and hepatocyte differentiation. FASEB J. 10 (1996) 267-282
2. Schrem H., Klempnauer J., and Borlak J. Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression. Pharmacol. Rev. 54 (2002) 129-158
3. Zaret K.S. Regulatory phases of early liver development: paradigms of organogenesis. Nat. Rev. Genet. 3 (2002) 499-512
4. Watt A.J., Garrison W.D., and Duncan S.A. HNF4: a central regulator of hepatocyte differentiation and function. Hepatology 37 (2003) 1249-1253
5. Parviz F., Matullo C., Garrison W.D., Savatski L., Adamson J.W., Ning G., Kaestner K.H., Rossi J.M., Zaret K.S., and Duncan S.A. Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat. Genet. 34 (2003) 292-296
6. Hayhurst G.P., Lee Y.H., Lambert G., Ward J.M., and Gonzalez F.J. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol. Cell. Biol. 21 (2001) 1393-1403
7. Sladek F.M., and Seidel S.D. Hepatocyte nuclear factor 4alpha. In: Burris T.P., and McCabe E.R.B. (Eds). Nuclear Receptors and Genetic Disease (2001), Academic Press, London 309-361
8. Rhee J., Inoue Y., Yoon J.C., Puigserver P., Fan M., Gonzalez F.J., and Spiegelman B.M. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc. Natl. Acad. Sci. U.S.A 100 (2003) 4012-4017
9. Beaudry J.B., Pierreux C.E., Hayhurst G.P., Plumb-Rudewiez N., Weiss M.C., Rousseau G.G., and Lemaigre F.P. Threshold levels of hepatocyte nuclear factor 6 (HNF-6) acting in synergy with HNF-4 and PGC-1alpha are required for time-specific gene expression during liver development. Mol. Cell. Biol. 26 (2006) 6037-6046
10. Odom D.T., Zizlsperger N., Gordon D.B., Bell G.W., Rinaldi N.J., Murray H.L., Volkert T.L., Schreiber J., Rolfe P.A., Gifford D.K., Fraenkel E., Bell G.I., and Young R.A. Control of pancreas and liver gene expression by HNF transcription factors. Science 303 (2004) 1378-1381
11. Kyrmizi I., Hatzis P., Katrakili N., Tronche F., Gonzalez F.J., and Talianidis I. Plasticity and expanding complexity of the hepatic transcription factor network during liver development. Genes Dev. 20 (2006) 2293-2305
12. Gupta R.K., Gao N., Gorski R.K., White P., Hardy O.T., Rafiq K., Brestelli J.E., Chen G., Stoeckert Jr. C.J., and Kaestner K.H. Expansion of adult beta-cell mass in response to increased metabolic demand is dependent on HNF-4alpha. Genes Dev. 21 (2007) 756-769
13. Shih D.Q., Dansky H.M., Fleisher M., Assmann G., Fajans S.S., and Stoffel M. Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels. Diabetes 49 (2000) 832-837
14. Taraviras S., Monaghan A.P., Schütz G., and Kelsey G. Characterization of the mouse HNF-4 gene and its expression during mouse embryogenesis. Mech. Dev. 48 (1994) 67-79
15. Zhong W., Mirkovitch J., and Darnell Jr. J.E. Tissue-specific regulation of mouse hepatocyte nuclear factor 4 expression. Mol. Cell. Biol. 14 (1994) 7276-7284
16. Hatzis P., and Talianidis I. Regulatory mechanisms controlling human hepatocyte nuclear factor 4alpha gene expression. Mol. Cell. Biol. 21 (2001) 7320-7330
17. Nakhei H., Lingott A., Lemm I., and Ryffel G.U. An alternative splice variant of the tissue specific transcription factor HNF4alpha predominates in undifferentiated murine cell types. Nucleic Acids Res. 26 (1998) 497-504
18. Boj S.F., Parrizas M., Maestro M.A., and Ferrer J. A transcription factor regulatory circuit in differentiated pancreatic cells. Proc. Natl. Acad. Sci. U.S.A 98 (2001) 14481-14486
19. Thomas H., Jaschkowitz K., Bulman M., Frayling T.M., Mitchell S.M., Roosen S., Lingott-Frieg A., Tack C.J., Ellard S., Ryffel G.U., and Hattersley A.T. A distant upstream promoter of the HNF-4alpha gene connects the transcription factors involved in maturity-onset diabetes of the young. Hum. Mol. Genet. 10 (2001) 2089-2097
20. Torres-Padilla M.E., Fougère-Deschatrette C., and Weiss M.C. Expression of HNF4alpha isoforms in mouse liver development is regulated by sequential promoter usage and constitutive 3' end splicing. Mech. Dev. 109 (2001) 183-193
21. Sladek F.M., Zhong W., Lai E., and Darnell Jr. J.E. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev. 4 (1990) 2353-2365
22. Torres-Padilla M.E., Sladek F.M., and Weiss M.C. Developmentally regulated N-terminal variants of the nuclear receptor hepatocyte nuclear factor 4alpha mediate multiple interactions through coactivator and corepressor-histone deacetylase complexes. J. Biol. Chem. 277 (2002) 44677-44687
23. Bailly A., Torres-Padilla M.E., Tinel A.P., and Weiss M.C. An enhancer element 6 kb upstream of the mouse HNF4alpha1 promoter is activated by glucocorticoids and liver-enriched transcription factors. Nucleic Acids Res. 29 (2001) 3495-3505
24. Hatzis P., and Talianidis I. Dynamics of enhancer-promoter communication during differentiation-induced gene activation. Mol. Cell 10 (2002) 1467-1477
25. Briançon N., and Weiss M.C. In vivo role of the HNF4alpha AF-1 activation domain revealed by exon swapping. EMBO J. 25 (2006) 1253-1262
26. Odom D.T., Dowell R.D., Jacobsen E.S., Nekludova L., Rolfe P.A., Danford T.W., Gifford D.K., Fraenkel E., Bell G.I., and Young R.A. Core transcriptional regulatory circuitry in human hepatocytes. Mol. Syst. Biol. 2 (2006) 2006.0017
27. Magenheim J., Hertz R., Berman I., Nousbeck J., and Bar-Tana J. Negative autoregulation of HNF-4alpha gene expression by HNF-4alpha1. Biochem. J. 388 (2005) 325-332
28. Oyadomari S., Matsuno F., Chowdhury S., Kimura T., Iwase K., Araki E., Shichiri M., Mori M., and Takiguchi M. The gene for hepatocyte nuclear factor (HNF)-4alpha is activated by glucocorticoids and glucagon, and repressed by insulin in rat liver. FEBS Lett. 478 (2000) 141-146
29. Michalopoulos G.K., Bowen W.C., Mulé K., and Luo J. HGF, EGF, and dexamethasone induced gene expression patterns during formation of tissue in hepatic organoid cultures. Gene Expr. 11 (2003) 55-75
30. Briançon N., Bailly A., Clotman F., Jacquemin P., Lemaigre F.P., and Weiss M.C. Expression of the alpha7 isoform of hepatocyte nuclear factor (HNF) 4 is activated by HNF6/OC-2 and HNF1 and repressed by HNF4alpha1 in the liver. J. Biol. Chem. 279 (2004) 33398-33408
31. Cereghini S., Raymondjean M., Carranca A.G., Herbomel P., and Yaniv M. Factors involved in control of tissue-specific expression of albumin gene. Cell 50 (1987) 627-638
32. Gresh L., Fischer E., Reimann A., Tanguy M., Garbay S., Shao X., Hiesberger T., Fiette L., Igarashi P., Yaniv M., and Pontoglio M. A transcriptional network in polycystic kidney disease. EMBO J. 23 (2004) 1657-1668
33. Landry C., Clotman F., Hioki T., Oda H., Picard J.J., Lemaigre F.P., and Rousseau G.G. HNF-6 is expressed in endoderm derivatives and nervous system of the mouse embryo and participates to the cross-regulatory network of liver-enriched transcription factors. Dev. Biol. 192 (1997) 247-257
34. Mietus-Snyder M., Sladek F.M., Ginsburg G.S., Kuo C.F., Ladias J.A.A., Darnell Jr. J.E., and Karathanasis S.K. Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cells. Mol. Cell. Biol. 12 (1992) 1708-1718
35. Wiley S.R., Kraus R.J., and Mertz J.E. Functional binding of the "TATA" box binding component of transcription factor TFIID to the -30 region of TATA-less promoters. Proc. Natl. Acad. Sci. U.S.A 89 (1992) 5814-5818
36. Wang Y., Kobori J.A., and Hood L. The ht beta gene encodes a novel CACCC box-binding protein that regulates T-cell receptor gene expression. Mol. Cell. Biol. 13 (1993) 5691-5701
37. Gumucio D.L., Rood K.L., Gray T.A., Riordan M.F., Sartor C.I., and Collins F.S. Nuclear proteins that bind the human gamma-globin gene promoter: alterations in binding produced by point mutations associated with hereditary persistence of fetal hemoglobin. Mol. Cell. Biol. 8 (1988) 5310-5322
38. Lemaigre F.P., Courtois S.J., Lafontaine D.A., and Rousseau G.G. Evidence that the upstream stimulatory factor and the Sp1 transcription factor bind in vitro to the promoter of the human-growth-hormone gene. Eur. J. Biochem. 181 (1989) 555-561
39. Berthelsen J., Zappavigna V., Ferretti E., Mavilio F., and Blasi F. The novel homeoprotein Prep1 modulates Pbx-Hox protein cooperativity. EMBO J. 17 (1998) 1434-1445
40. Hale T.K., and Braithwaite A.W. The adenovirus oncoprotein E1a stimulates binding of transcription factor ETF to transcriptionally activate the p53 gene. J. Biol. Chem. 274 (1999) 23777-23786
41. Nehls M.C., Rippe R.A., Veloz L., and Brenner D.A. Transcription factors nuclear factor I and Sp1 interact with the murine collagen alpha 1 (I) promoter. Mol. Cell. Biol. 11 (1991) 4065-4073
42. Durand B., Saunders M., Leroy P., Leid M., and Chambon P. All-trans and 9-cis retinoic acid induction of CRABPII transcription is mediated by RAR-RXR heterodimers bound to DR1 and DR2 repeated motifs. Cell 71 (1992) 73-85
43. Lemaigre F.P., Durviaux S.M., and Rousseau G.G. Liver-specific factor binding to the liver promoter of a 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene. J. Biol. Chem. 268 (1993) 19896-19905
44. Wang N.D., Finegold M.J., Bradley A., Ou C.N., Abdelsayed S.V., Wilde M.D., Taylor L.R., Wilson D.R., and Darlington G.J. Impaired energy homeostasis in C/EBP alpha knockout mice. Science 269 (1995) 1108-1112
45. Opherk C., Tronche F., Kellendonk C., Kohlmüller D., Schulze A., Schmid W., and Schütz G. Inactivation of the glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus. Mol. Endocrinol. 18 (2004) 1346-1353
46. Tian J.M., and Schibler U. Tissue-specific expression of the gene encoding hepatocyte nuclear factor 1 may involve hepatocyte nuclear factor 4. Genes Dev. 5 (1991) 2225-2234
47. Kuo C.J., Conley P.B., Chen L., Sladek F.M., Darnell Jr. J.E., and Crabtree G.R. A transcriptional hierarchy involved in mammalian cell-type specification. Nature 355 (1992) 457-461
48. Bulla G.A., and Fournier R.E.K. Genetic analysis of a transcriptional activation pathway by using hepatoma cell variants. Mol. Cell. Biol. 14 (1994) 7086-7094
49. Späth G.F., and Weiss M.C. Hepatocyte nuclear factor 4 expression overcomes repression of the hepatic phenotype in dedifferentiated hepatoma cells. Mol. Cell. Biol. 17 (1997) 1913-1922
50. Bailly A., Späth G., Bender V., and Weiss M.C. Phenotypic effects of the forced expression of HNF4 and HNF1alpha are conditioned by properties of the recipient cell. J. Cell Sci. 111 (1998) 2411-2421
51. Kardassis D., Falvey E., Tsantili P., Hadzopoulou-Cladaras M., and Zannis V. Direct physical interactions between HNF-4 and Sp1 mediate synergistic transactivation of the apolipoprotein CIII promoter. Biochemistry 41 (2002) 1217-1228
52. Hwang-Verslues W.W., and Sladek F.M. Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter. Mol. Endocrinol. 22 (2008) 78-90
53. Sladek F.M., Ruse Jr. M.D., Nepomuceno L., Huang S.M., and Stallcup M.R. Modulation of transcriptional activation and coactivator interaction by a splicing variation in the F domain of nuclear receptor hepatocyte nuclear factor 4alpha1. Mol. Cell. Biol. 19 (1999) 6509-6522
54. Price J.A., Fossey S.C., Sale M.M., Brewer C.S., Freedman B.I., Wuerth J.P., and Bowden D.W. Analysis of the HNF4 alpha gene in Caucasian type II diabetic nephropathic patients. Diabetologia 43 (2000) 364-372